EP1514216A4 - Erzeugung und auswahl einer proteinbibliothek in silico - Google Patents

Erzeugung und auswahl einer proteinbibliothek in silico

Info

Publication number
EP1514216A4
EP1514216A4 EP03755415A EP03755415A EP1514216A4 EP 1514216 A4 EP1514216 A4 EP 1514216A4 EP 03755415 A EP03755415 A EP 03755415A EP 03755415 A EP03755415 A EP 03755415A EP 1514216 A4 EP1514216 A4 EP 1514216A4
Authority
EP
European Patent Office
Prior art keywords
silica
selection
production
protein bank
bank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03755415A
Other languages
English (en)
French (fr)
Other versions
EP1514216A2 (de
Inventor
Peizhi Luo
Mark Hsieh
Pingyu Zhong
Caili Wang
Yicheng Cao
Shengjiang Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abmaxis Inc
Original Assignee
Abmaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/153,176 external-priority patent/US20030022240A1/en
Priority claimed from US10/153,159 external-priority patent/US7117096B2/en
Application filed by Abmaxis Inc filed Critical Abmaxis Inc
Publication of EP1514216A2 publication Critical patent/EP1514216A2/de
Publication of EP1514216A4 publication Critical patent/EP1514216A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20—Screening of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Library & Information Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Computing Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP03755415A 2002-05-20 2003-05-20 Erzeugung und auswahl einer proteinbibliothek in silico Withdrawn EP1514216A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US153176 1980-05-27
US153159 1988-02-08
US10/153,176 US20030022240A1 (en) 2001-04-17 2002-05-20 Generation and affinity maturation of antibody library in silico
US10/153,159 US7117096B2 (en) 2001-04-17 2002-05-20 Structure-based selection and affinity maturation of antibody library
PCT/US2003/016037 WO2003099999A2 (en) 2002-05-20 2003-05-20 Generation and selection of protein library in silico

Publications (2)

Publication Number Publication Date
EP1514216A2 EP1514216A2 (de) 2005-03-16
EP1514216A4 true EP1514216A4 (de) 2010-01-06

Family

ID=29586304

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03755415A Withdrawn EP1514216A4 (de) 2002-05-20 2003-05-20 Erzeugung und auswahl einer proteinbibliothek in silico

Country Status (7)

Country Link
EP (1) EP1514216A4 (de)
JP (1) JP2005526518A (de)
CN (1) CN1672160B (de)
AU (1) AU2003248548B2 (de)
CA (1) CA2485732A1 (de)
SG (1) SG135053A1 (de)
WO (1) WO2003099999A2 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7667004B2 (en) * 2001-04-17 2010-02-23 Abmaxis, Inc. Humanized antibodies against vascular endothelial growth factor
AU2004202566B2 (en) * 2004-06-11 2011-07-21 Li-Te Chin Method for Producing Human Antibodies with Properties of Agonist, Antagonist, or Inverse Agonist
CZ200755A3 (cs) 2004-07-26 2007-04-11 Biogen Idec Ma Inc. Peptidy protilátek anti-CD154
DK3540062T3 (da) * 2004-11-16 2021-06-28 Humanigen Inc Immunoglobulin-variabel region kassetteudskiftning
AU2006220709B2 (en) 2005-03-04 2012-09-06 Biogen Ma Inc. Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
JP4997239B2 (ja) 2005-07-22 2012-08-08 ワイズ・エー・シー株式会社 抗ｃｄ２６抗体およびその使用方法
CA2646508A1 (en) * 2006-03-17 2007-09-27 Biogen Idec Ma Inc. Stabilized polypeptide compositions
CN101548034B (zh) * 2006-10-02 2013-11-13 航道生物技术有限责任公司 多样性合成肽和多肽文库的设计和构建
EP2118795A4 (de) * 2007-01-31 2010-07-07 Sundia Meditech Company Ltd Verfahren, systeme, algorithmen und mittel zur beschreibung der möglichen konformationen realer und theroretischer proteine sowie zur beurteilung realer und theroretischer proteine hinsichtlich faltung, gesamtform und strukturmotiven
CA2742968C (en) * 2008-11-07 2020-06-09 Fabrus Llc Combinatorial antibody libraries and uses thereof
ES2534355T3 (es) * 2009-06-17 2015-04-21 Abbvie Biotherapeutics Inc. Anticuerpos anti-VEGF y sus usos
ES2826883T3 (es) * 2009-10-14 2021-05-19 Janssen Biotech Inc Métodos de maduración por afinidad de anticuerpos
WO2013171810A1 (ja) 2012-05-14 2013-11-21 パナソニック株式会社 耐熱性抗体提示ファージを得る方法
US20140154255A1 (en) 2012-11-30 2014-06-05 Abbvie Biotherapeutics Inc. Anti-vegf antibodies and their uses
JP6377078B2 (ja) * 2013-01-31 2018-08-22 コデクシス， インコーポレイテッド 相互作用する構成要素を有する生体分子を同定するための方法、システム、およびソフトウェア
CN104805507B (zh) * 2014-01-29 2019-01-22 杭州康万达医药科技有限公司 噬菌体展示文库及其应用和制备方法
CA2989383A1 (en) * 2014-07-07 2016-01-14 Yeda Research And Development Co. Ltd. Method of computational protein design
GB201500464D0 (en) * 2015-01-12 2015-02-25 Crescendo Biolog Ltd Method of producing optimised therapeutic molecules
WO2016137992A2 (en) * 2015-02-24 2016-09-01 Academia Sinica A phage-displayed single-chain variable fragment library
CN104789555A (zh) * 2015-04-29 2015-07-22 江南大学 一种基于合成单链dna文库进化基因表达调控元件的方法
JP6558754B2 (ja) 2015-08-07 2019-08-14 富士通株式会社 情報処理装置、指標次元抽出方法、および指標次元抽出プログラム
UA125432C2 (uk) * 2015-09-23 2022-03-09 Дженентек, Інк. Оптимізовані варіанти анти-vegf антитіл
CN106290908A (zh) * 2016-08-07 2017-01-04 查文娟 一种用于肾脏损伤检测用试剂盒
JP6778932B2 (ja) * 2016-09-16 2020-11-04 国立大学法人大阪大学 免疫実体クラスタリングソフトウェア
CN106905435B (zh) * 2017-03-13 2020-04-10 武汉海沙百得生物技术有限公司 一种制备基于蛋白a突变体的结合蛋白的方法
AU2018256367A1 (en) * 2017-04-18 2019-11-28 X-Chem, Inc. Methods for identifying compounds
EP3669018A4 (de) * 2017-08-18 2021-05-26 Nautilus Biotechnology, Inc. Verfahren zur auswahl von bindungsreagenzien
KR102615744B1 (ko) * 2017-11-20 2023-12-19 난트바이오 인코포레이티드 mRNA 디스플레이 항체 라이브러리 및 방법(mRNA DISPLAY ANTIBODY LIBRARY AND METHODS)
CN108304691B (zh) * 2018-02-09 2021-05-18 北京矿冶科技集团有限公司 基于片段的浮选药剂分子设计方法
CN108491692B (zh) * 2018-03-09 2023-07-21 中国科学院生态环境研究中心 一种构建抗生素抗性基因数据库的方法
CN108763870B (zh) * 2018-05-09 2021-08-03 浙江工业大学 一种多域蛋白质Linker构建方法
CN109002690B (zh) * 2018-06-08 2021-05-18 济南大学 通过构建charmm rotamers力场预测突变氨基酸侧链结构的方法
CN108959846B (zh) * 2018-07-03 2021-09-14 南昌立德生物技术有限公司 一种计算机辅助先导药物优化设计的亲和自由能分解算法
CN109243526B (zh) * 2018-07-12 2021-08-03 浙江工业大学 一种基于特定片段交叉的蛋白质结构预测方法
CN109086568B (zh) * 2018-08-16 2022-03-11 福建工程学院 计算机抗体组合突变进化系统及方法、信息数据处理终端
CN109801679B (zh) * 2019-01-15 2021-02-02 广州柿宝生物科技有限公司 一种用于长链分子的数学序列重建方法
JP7524215B2 (ja) * 2019-04-09 2024-07-29 エーテーハー チューリッヒ 抗体を分類するためのシステムおよび方法
US20220253669A1 (en) * 2019-06-07 2022-08-11 Chugai Seiyaku Kabushiki Kaisha Information processing system, information processing method, program, and method for producing antigen-binding molecule or protein
EP3990116A1 (de) * 2019-06-28 2022-05-04 Gensun Biopharma Inc. Antitumor-antagonist bestehend aus einer mutierten tgfss1-rii-extrazellulären domäne und einem immunoglobulin-gerüst
AU2021210992A1 (en) * 2020-01-23 2022-08-04 Massachusetts Institute Of Technology Methods of functionally screening biological sequence fragments
CN115349128A (zh) * 2020-02-13 2022-11-15 齐默尔根公司 宏基因组文库和天然产物发现平台
CN111370074B (zh) * 2020-02-27 2023-07-07 北京晶泰科技有限公司 一种分子序列的生成方法、装置和计算设备
CN111462815B (zh) * 2020-03-27 2023-05-02 上海祥耀生物科技有限责任公司 一种抗体库的构建方法及装置
CN112102883B (zh) * 2020-08-20 2023-12-08 深圳华大生命科学研究院 一种fastq文件压缩中的碱基序列编码方法和系统
CN121034391B (zh) * 2025-10-28 2026-02-10 天津安百胜医疗科技有限公司 基于粗粒化结构模型的抗原抗体对接与抗体生成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002084277A1 (en) * 2001-04-17 2002-10-24 Abmaxis, Inc. Structure-based construction of human antibody library

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006625A1 (en) * 1994-08-26 1996-03-07 Eli Lilly And Company Antibody constructs with cdr switched variable regions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002084277A1 (en) * 2001-04-17 2002-10-24 Abmaxis, Inc. Structure-based construction of human antibody library

Also Published As

Publication number Publication date
CN1672160A (zh) 2005-09-21
WO2003099999A2 (en) 2003-12-04
WO2003099999A3 (en) 2004-09-16
AU2003248548A1 (en) 2003-12-12
EP1514216A2 (de) 2005-03-16
SG135053A1 (en) 2007-09-28
CN1672160B (zh) 2010-06-09
CA2485732A1 (en) 2003-12-04
JP2005526518A (ja) 2005-09-08
AU2003248548B2 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
EP1514216A4 (de) Erzeugung und auswahl einer proteinbibliothek in silico
EP1545600A4 (de) Protein- und peptid-expression für passive immunität
EP1495055A4 (de) Herstellung von funktionellen antikörpern in filamentösen pilzen
EP1451293A4 (de) Neue sulfurylase-luciferase-fusionsproteine und temperaturstabile sulfurylase
NO20040246L (no) TACI'er- og BR3-polypeptider og anvendelser derav
EP1427746A4 (de) Systeme zur expression von proteinen und nukleinsäuren
EP1531851A4 (de) Kovalente konjugate zwischen mit artemisinin verwandten endoperoxiden und eisentragenden proteinen und anwendungsverfahren
EP1660638A4 (de) Lipopartikel umfassende proteine, verfahren zur herstellung und verwendung davon
FR14C0007I1 (fr) Remodelage et glycoconjugaison de peptides
EP1427494A4 (de) Verfahrensverifikation
EP1713916A4 (de) Neue, aus einer menschlichen embryonalen stammzelle isolierte mirna-moleküle
EP1390741A4 (de) Auf strukturen beruhende konstruktion einer bibliothek menschlicher antikörper
ITMI20000227A0 (it) Ammidi utili nell'inibizione della chemiotassi dei neutrofili indottada il-8
FR2831769B1 (fr) Facteur d'appetence et exhausteur de gout
ID24409A (id) Struktur suatu jembatan gitar
DE60235527D1 (de) Erkennung von grenzflächen in einem erdformationsübergang
EP1637598A4 (de) Cd47-teilpeptid und monoklonaler anti-shps-1-antikörper
EP1444245A4 (de) Neue chromophore/fluorophore und verfahren zu deren anwendung
EP1370579A4 (de) Matrixgenexpression bei der chondrogenese
FR2824092B1 (fr) Ensemble d'elements de construction
EP1464701A4 (de) Fluoreszenzproteine
EP1456418A4 (de) Identifizierung neuer polymorpher orte im menschlichen mglur8-gen und verwendungen davon
DE60203475D1 (de) Drosselklappe und Drossel
EP1596803A4 (de) Transiente produktion pharmazeutisch wichtiger proteine in pflanzen
MA27184A1 (fr) Dosage d'anticorps anti-ingap

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041220

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1069460

Country of ref document: HK

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: LIU, SHENGJIANG

Inventor name: CAO, YICHENG

Inventor name: WANG, CAILI

Inventor name: ZHONG, PINGYU

Inventor name: HSIEH, MARKMERCK & CO, INC

Inventor name: LUO, PEIZHIMERCK & CO, INC

A4 Supplementary search report drawn up and despatched

Effective date: 20091204

17Q First examination report despatched

Effective date: 20110221

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1069460

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203